focus -WSS

focus

author：hotspot 2025-10-06 19:10:06 - browse：56

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： What causes an itch? Researchers may have solved the mystery

WSS

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Astellas still sees hope in its gene therapy after four deaths

Why sickle cell disease is getting the first CRISPR treatment

World's first CRISPR

What causes an itch? Researchers may have solved the mystery

FDA approves world's first CRISPR

explore

focus

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Americans' trust in science, scientist continues decline: Report

Novavax promises a turnaround & Lilly roils the obesity market

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Malaria cases in Florida and Texas: Here’s what you need to know

NYU radiologists take on the challenge of expensive MRI machines

Wildfire smoke exposes gaps in outdoor worker protections

U.K. considers world's first use of meningitis vaccine to address gonorrhea

knowledge

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Spinal cord stimulation reduces pain in amputees, study finds

STAT letters to the editor on burnt

Gain of function research would be limited under House proposal

FDA approves world's first CRISPR

Congenital heart disease patients face new threat of heart failure

Wikipedia

entertainment

knowledge

hotspot